Introduction {#Sec1}
============

Basal cell carcinoma (BCC) is the most common cutaneous malignancy and accounts for approximately 80 percent of all nonmelanoma skin cancers \[[@CR1]\]. Exposure to ultraviolet radiation is the main environmental risk factor associated with the development of BCCs, although they have also been found to occur less frequently in photo-protected sites. Albeit rare, BCCs of the nipple-areola complex (NAC) have been suggested as being more aggressive with higher rates of metastasis to regional lymph nodes \[[@CR2]\]. To date, three cases of BCC of the NAC metastatic to the lymph nodes have been described. In comparison, metastatic BCCs from all anatomic sites have been described in a total of 364 cases from 1894 through 2011 \[[@CR3]\]. As a result, there has been controversy over the management of BCCs of the NAC.

To address the surveillance and management of BCC of the NAC, an extensive world literature review was conducted to identify cases reported between 1893 and 2016. We review the characteristics of individuals who developed BCCs of the NAC and their management.

Methods {#Sec2}
=======

Using the PubMed database, a literature search was performed searching for articles related to BCC of the nipple or NAC published in the world literature. The following keywords were used: areola, basal cell carcinoma, and nipple. Relevant papers were reviewed, and the references cited in these papers were evaluated. Information pertaining to age, sex, site of BCC, morphology of BCC, histological subtype of BCC, presence of pigment on histology, previous history of BCC, risk factors, treatment, lymph node involvement, and clinical outcome was identified from each case report. Additional informed consent was obtained from one patient for whom identifying information is included in this article.

Results {#Sec3}
=======

Fifty-five patients with BCC of the nipple and areola have been reported in the world literature, including the patient described in Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"} (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}) \[[@CR2], [@CR4]--[@CR51]\]. BCC of this site occurred more frequently in males (35, 63.6%) than in females (20, 36.4%). The onset age ranged from 35 to 86 years old. The median onset age in males was 61 years, whereas the median onset age in females was 66 years. The onset age was not mentioned for one female \[[@CR6]\].Fig. 1**a**, **b** A previously unreported clinical presentation of basal cell carcinoma of the areola. Distant view (**a**) of a flesh-colored to hypopigmented dermal nodule on the upper medial quadrant of the right areola in a 67-year-old Caucasian male with Fitzpatrick skin type 2. He had a prior history of basal cell carcinoma on the left arm diagnosed 3 years earlier and presented with a 6-month history of a slowly enlarging, asymptomatic lesion on the right areola and adjacent breast. He had a prior history of moderate sun exposure as a young adult. He had no exposure to ionizing radiation and had no family history of basal cell carcinoma or basal cell nevus syndrome. Closer view (**b**) of the right breast shows the 7 × 7-mm flesh-colored to hypopigmented dermal nodule on the upper medial quadrant of his right areola and extending into the adjacent breast. A 3-mm punch biopsy was performed. The patient in these figures is also cited in Table [1](#Tab1){ref-type="table"} (case 35)Fig. 2**a**, **b** A previously unreported pathologic presentation of the basal cell carcinoma of the areola shown in Fig. [1](#Fig1){ref-type="fig"}. Low (**a**) and higher (**b**) magnification views of the pigmented basal cell carcinoma show nodular aggregates of basaloid tumor cells extending from the epidermis into the dermis (**a**). Deposits of melanin were present not only in the tumor cells but also in dermal melanophages (**b**). The residual tumor was excised using the Mohs micrographic technique, and clear margins were achieved after three stages. The final wound measured 20 × 14 mm and a layered side-to-side closure was used to close the surgical defect. The patient in these figures is also cited in Table [1](#Tab1){ref-type="table"} (case 35)Table 1Clinical characteristics of males with basal cell carcinoma of the nipple-areola complexCaseAge (years)RaceLocMorphologyHist subPOther NMSCsRisk factorsRxOutcomeReferences160NSR N, AIrregular ulcerated patchNS--NSNSSimple excision and axillary LyN samplingNo recurrence\
Died 18 months later of unrelated causeRobinson \[[@CR4]\]257NSL NNSNSNSNSNSNSLyN involvement\
Died of disease in 8 yearsWainwright \[[@CR5]\]343WNNSNod+^a^NSNSSimple mastectomyNo recurrence after 1 yearCongdon et al. \[[@CR6]\]449NSR NScaly and crusted lesion with ulceration and scar^b^NSNSNSNSWide excisionNSFarrow \[[@CR7]\]571WR N, A8-cm tumor with ulcerationNod--NSNSSimple mastectomyLyN involved\
After mastectomy, no recurrenceWyatt \[[@CR8]\]672NSR NEnlarged, firm R nipple^b^Nod--NSNSWide excisionNSLupton et al. \[[@CR9]\]772NSL N, ANSNSNSNSNSNSNSC2, Rahbari et al. \[[@CR10]\]847NSL ANSNSNSNSNSNSNSC22, Rahbari et al. \[[@CR10]\]949WR APink, red plaqueNSNSNSNSMMSClear margins at surgeryRobins et al. \[[@CR11]\]1053WL NUlcerated lesion^b^Nod--NSNSSimple excisionClear margins at surgeryKnudsen \[[@CR12]\]^c^1151WL N, AReddish brown, scaly, indurated plaque with pearly rolled borderS--NoneSun exposureSimple excisionClear margins at surgeryBruce et al. \[[@CR13]\]1258NSL NSkin breakdown of L nipple^b^M: Nod, I--NoneNoneSimple excision followed by radiotherapy4 Years later had recurrence in axillary LyN, treated with mastectomy and LyN clearanceShertz et al. \[[@CR2]\]1386NSR NRed, scaly, ulcerated oozing lesion^b^F--BCC and SCC on face and scalpTrauma to the chestSimple excision^d^NSNirodi et al. \[[@CR14]\]1463WR N, AEroded plaque with crustNod--NSNoneSimple excisionNo recurrence after 16 monthsC1, Cain et al. \[[@CR15]\]1580WR N, AIndurated reddish brown mass with ulceration^b^F--NSNSWide excisionNo recurrence after 8 monthsC2, Cain et al. \[[@CR15]\]1668WL N2 cm reddish brown to gray and blackish bluish noduleSup+^e^NSNSSimple excisionClear margins at surgeryTitzmann et al. \[[@CR16]\]^f^1757WR N1.5 cm papuleNod--BCC × 4 on face and armsSun exposure, although noted patient states he always wore a shirtSimple mastectomyNo recurrence after 2 yearsBenharroch et al. \[[@CR17]\]1855NSN, ANSBCCNSNSNSMMSNSWeber et al. \[[@CR18]\]1957WR NFlesh colored, indurated papuleNod--NoneNoneWide excisionNo recurrence after 5 yearsC1, Betti et al. \[[@CR19]\]2039WN, AWell-limited plaque with crustSup--NSNoneWide excisionNo recurrence after 2 yearsC2, Betti et al. \[[@CR19]\]2167WL N,AUlcerated, erythematous lesion^b^Nod--BCC foreheadNSWide excisionClear margins at surgeryGupta et al. \[[@CR20]\]2261WL APink, pearly papuleNSNSBCC × 2 on abdomenBurn to chest wall from fireMMSClear margins at surgeryNouri et al. \[[@CR21]\]2378NSL N, AErythematous nodule with crusting and swellingNod--NSNoneSimple mastectomy with LyN dissectionClear at surgeryKim et al. \[[@CR22]\]^g^2460WL NErythematous ulcer with scale and crust^b^F--NoneNoneSimple mastectomyClear at surgeryAvci et al. \[[@CR23]\]2869WL N, AErythematous plaque with crustNSNSNSNSMMSNo recurrence after 6 monthsCummins et al. \[[@CR24]\]2560WL NEnlarged L nipple^b^M: S, MN--BCCsSunRefused excisionLost to follow-upOram et al. \[[@CR25]\]2676WL NUlcerated lesion on L nipple^b^Nod--NSNSNSNSKacerovska et al. \[[@CR26]\]2769WR NPoorly defined, pink, telangiectatic plaque with ulcerationM: Nod, S--NoneSun exposureMMSNo recurrence after 2 yearsSinha et al. \[[@CR27]\]2942WL N, APoorly defined erythematous plaqueM: Nod, S--BCCsBCNS, immune-suppressedMMSNo recurrence after 3 monthsWilliams et al. \[[@CR28]\]3023NSR NWell-defined pink, semicircular papule with multiple pin-point pigmented macules on the nippleNS+^e^NSNSSimple excisionNo recurrence after 5 yearsBrown et al. \[[@CR29]\]3178AsianL N, APigmented maculeNod+^e^NoneNoneSimple excisionDisease free at 1 yearKalyani et al. \[[@CR30]\]3278AsianR NPigmented mass with ulceration^b^S^b^+^e^NSGastric cancer, chemoSimple excisionNo recurrence at 6 monthsTakeno et al. \[[@CR31]\]3375WR NErythematous ulcer on R nipple^b^S--Surgical excision of nod BCC 3 years priorNSMMS showed lactiferous ducts were infiltrated, so simple mastectomy was performedClear margins after simple mastectomyMiglino et al. \[[@CR32]\]3465NSR NIrregular, black maculeS+^e^NSNSNSNSKitamura et al. \[[@CR33]\]3567WR AFlesh colored to Hypopigmented noduleNod+^h^BCC of L armNoneMMSNo recurrence after 6 monthsChun et al.^i^ CR*A* areola, *BCNS* basal cell nevus syndrome, *Cm* centimeter, *CR* current report, *F* fibroepithelioma of pinkus, *Hist sub* histologic subtype, *I* infiltrative, *L* left, *Loc* location, *LyN* lymph node, *M* mixed, *MMS* Mohs micrographic surgery, *MN* micronodular, *N* nipple, *Nod* nodular, *NS* not stated, *P* pigmented; *S* superficial, *W* white, *Y* years^a^Tumor is microscopically pigmented. Clinical presentation was not stated^b^Primary morphology not stated^c^Article in Danish^d^For this patient, the nipple was excised^e^Tumor is both clinically and microscopically pigmented^f^Article in German^g^Article in Korean^h^Tumor is microscopically pigmented, but not clinically pigmented^i^Presented in Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}^j^Simple excision is defined as excision with narrower margins if visually normal-appearing skin^k^Wide local excision is defined as involving a larger margin of normal-appearing skinTable 2Clinical characteristics of females with basal cell carcinoma of the nipple-areola complexCaseAge (years)RaceLocMorphologyHistoPOther NMSCsRisk factorsRxOutcomeReferences1NSNSNNSNSNSNSNSSimple mastectomyAlive and disease free at 2 yearsCongdon et al. \[[@CR6]\]266WL NRed, scaly nipple with induration^a^S--NSNSWide excisionClear margins at surgeryDavis et al. \[[@CR34]\]367WL N, AErythematous, eczematous noduleS--NoneSmokerEtretinate followed by simple mastectomyClear margins at surgeryJones et al. \[[@CR35]\]449NSN, ANSNSNSNSNSNo treatmentNSBetti et al. \[[@CR36]\]571WBilateral AScaly plaques. Plaque on left breast with ulcerationSNSBCC, melanomaNSWide excisionNo recurrence after 6 monthsWong et al. \[[@CR37]\]635NSL ARed plaque with well-defined bordersS--NoneNoneSimple excisionNo recurrence after 1 yearNunez et al. \[[@CR38]\]775NSL N, ARed, eczematous lesion^a^M: Nod, S--NSNSWide excision followed by radiotherapyClear margins at surgerySauven et al. \[[@CR39]\]865NSL N, AErythematous, indurated plaque with ulcerationM: Nod, I--NoneModerate sun exposureMMSNo recurrence after 1 yearSanchez- Carpintero et al. \[[@CR40]\]982AsianL ADark brown papuleNod+^b^NoneNoneWide\
ExcisionDisease free after 2 yearsYamamoto et al. \[[@CR41]\]1047HL N, AIll-defined erythematous plaqueS--NoneNoneMMSClear margins at surgeryZhu et al. \[[@CR42]\]1147WL N, ARed-brown, indurated noduleNod--NoneNoneWide excisionNo recurrence after 2 yearsC3, Betti et al. \[[@CR19]\]1246AsianR AWell-defined, slightly crusted plaqueS--NoneNoneInitially had simple excision, but due to positive margins had a simple mastectomy and excision of an axillary sentinel LyNDisease free after 1 yearHuang et al. \[[@CR43]\]1349WL N,AIndurated red-brown plaqueM: S, I--NoneTopless sunbathingMMS with sentinel LyN biopsyClear margins at surgeryRosen et al. \[[@CR44]\]1474NSR NEczematous lesion^a^S--NSNSSimple excisionClear margins at surgeryChu et al. \[[@CR45]\]1567AsianR ABlack hyperkeratotic plaqueNod+^b^NoneNoneWide excisionDisease free after 14 monthsJung et al. \[[@CR46]\]1648NSR N, AHyperpigmented, erythematous plaque with ulcerationNod+^b^NoneNoneSimple excisionClear margins at surgerySharma et al. \[[@CR47]\]1772AsianR N, AErythematous ulcer with scale and crust^a^F--NSNSWide excisionNSXu et al. \[[@CR48]\]1840WR NUlcerated noduleNod--NoneNoneSimple excisionNo recurrence after 18 monthsTrignano et al. \[[@CR49]\]1966AAL ALichenified, scaly, excoriated plaqueS+^e^NSNS5-FU BID x 6 weeksResolved clinically, but recurred after 22 monthsGoddard et al. \[[@CR50]\]2082WL NNoduleNod--NSNSWide excisionNo recurrence after 3 yearsOzerdem et al. \[[@CR51]\]*A* areola, *AA* African American, *F* fibroepithelioma of pinkus, *Hist sub* histologic subtype, *I* infiltrative, *L* left, *Loc* location, *LyN* lymph node, *M* mixed, *MMS* Mohs micrographic surgery, *N* nipple, *Nod* nodular, *NS* not stated, *R* right, *S* superficial, *Y* years^a^Primary morphology not stated^b^Tumor is both clinically and microscopically pigmented^c^Simple excision is defined as excision with narrower margins if visually normal-appearing skin^d^Wide local excision is defined as involving a larger margin of normal-appearing skin^e^Tumor is microscopically pigmented, but not clinically pigmented

BCCs of the nipple-areola complex were observed on the left (28/51, 54.9%) more frequently than the right (23/51, 45.1%). One patient had bilateral involvement of the areola \[[@CR37]\]. Five cases did not report the side affected. The nipple was affected in 45 patients (81.8%); 22 of these individuals also had tumors that affected the areola.

The majority of patients reported were Caucasian (28/37, 75.7%). However, BCC of the NAC was also described in 7 Asians (18.9%), 1 African American (2.7%), and 1 Hispanic (2.7%) patient. Ethnicity or race was not described in 18 cases.

Clinical presentation was variable and presented as a plaque (17/34, 50%), nodule (8/34, 23.5%), papule (6/34, 17.6%), macule (2/34, 5.9%), or patch (1/34, 2.9%). Secondary changes were additionally noted: ulceration or erosion of the BCC was noted in 19 cases, scale in 10, and crust in 7. Clinically, eight BCCs were pigmented.

The most frequent BCC histologic type reported was nodular (18/42, 42.9%). Other histologic subtypes of BCC observed were superficial (13/42, 30.9%), mixed (7/42, 16.7%), fibroepithelioma of pinkus (4/42, 9.5%), and pigmented (11/42, 26.2%). Of mixed subtypes, four were noted to have aggressive features on histology, including infiltrative (3/7, 42.9%) and micronodular (1/7, 14.3%). Thirteen cases did not provide a histological subtype of BCC.

Removal of the tumor was the most common treatment (Tables [1](#Tab1){ref-type="table"}, [2](#Tab2){ref-type="table"}, and [3](#Tab3){ref-type="table"}). This included either simple excision, being the most frequently performed (15/50, 30%), wide excision (14/50, 28%), or Mohs micrographic surgery (11/50, 22%) with examination of the margins during the excision to confirm complete tumor removal. Six patients had simple mastectomies as their initial modality of treatment (6/50, 12%).Table 3Initial treatment of basal cell carcinomas of the nipple-areola complexInitial treatment^a^Males^b^Femalesn^c^Total^d^Simple excision10^e^5^f^15Wide excision68^g^14MMS8^h^311Simple mastectomy51^i^6^j^5-Fluorouracil01^k^1Etretinate01^l^1No treatment112Total302050*MMS* Mohs micrographic surgery^a^Initial treatment not stated in 5 males^b^Number of males for whom treatment was performed^c^Number of females for whom treatment was performed^d^Total number of males and females for whom treatment was performed^e^This group includes one patient whose nipple was excised, and the excision type was not specified. Two patients had subsequent treatment including either axillary lymph node sampling or radiotherapy^f^One female had additional treatment: simple mastectomy and lymph node sampling^g^One female had additional treatment: radiotherapy^h^Following MMS, one male had a simple mastectomy^i^One female was treated with etretinate and subsequently had a simple mastectomy^j^Simple mastectomy was the initial treatment for six patients; however, nine mastectomies were eventually performed. One male was initially treated with MMS, and one female initially treated by simple excision followed by radiotherapy; one female was initially treated with etretinate^k^One female was treated with 5-fluorouracil twice daily for 6 weeks. The BCC initially resolved, but recurred at 22 months^l^Following etretinate therapy, one female had a simple mastectomy

One patient received topical 5-flourouracil (5-FU) twice daily for 6 weeks \[[@CR50]\]. One female was treated with etretinate followed by simple mastectomy \[[@CR35]\]. In addition, two patients received no treatment \[[@CR25], [@CR36]\]. In five males, there was no mention of management.

One male had Mohs micrographic surgery, which showed the lactiferous ducts had been infiltrated; thus, a simple mastectomy was performed (2%) \[[@CR32]\]. One male had a simple excision followed by radiotherapy, but 4 years later was noted to have recurrence in the axillary lymph node and thus had a simple mastectomy (2%) \[[@CR2]\]. One female had a simple excision, but due to positive margins, she subsequently had a partial mastectomy (2%) \[[@CR43]\].

Most of the patients (43/45, 95.6%) had no recurrence after successful treatment of their tumor. In ten patients, there was no mention of clinical outcome. There had been three reported cases of metastatic disease to the lymph nodes at the time of this review, and of these patients, one died from the disease.

Discussion {#Sec4}
==========

BCCs infrequently occur at unusual sites, such as the nipple and areola. Previous studies have noted a close histogenic relationship between BCCs and pilosebaceous units \[[@CR52]--[@CR54]\], and BCCs are therefore thought to arise in proportion to the number of pilosebaceous units present \[[@CR25]\]. The nipple and areola are deficient in these units, which may explain the paucity of BCCs of the nipple and areola.

After an extensive world literature search, we identified 55 cases of BCC of the NAC from 1893 to 2016 (123 years). A 2009 review by Ferguson et al. revealed 33 cases of BCC of the nipple and areola \[[@CR55]\]. Since 2009, 22 additional cases of BCC of the NAC have been reported in the world literature. This apparent increase in BCCs of this site may be due to a publication bias; however, this trend reflects an overall increased incidence of sporadic BCCs \[[@CR56]\].

The increased incidence of BCC of the NAC observed in males (35, 63.6%) versus females (20, 36.4%) \[[@CR2], [@CR4]--[@CR51]\] has been attributed to greater sun exposure of the chest in males \[[@CR2], [@CR13], [@CR15], [@CR20], [@CR27], [@CR41], [@CR42]\]. Although ultraviolent light exposure is the major risk factor for the development of BCC, other etiologies include arsenic exposure, genetic predisposition, environmental exposures, immunosuppression, ionizing radiation exposure, injury (burns or trauma), light-colored skin, previous BCCs at another site, and sunburns. Although the majority of cases did not reveal possible risk factors of BCC of the NAC, our review revealed two males (Table [1](#Tab1){ref-type="table"}, cases 11 and 26) \[[@CR13], [@CR27]\] and two females (Table [2](#Tab2){ref-type="table"}, cases 8 and 13) \[[@CR40], [@CR44]\] had increased sun exposure to the chest from shirtless sunbathing. Nine patients (9/26, 34.6%) had a prior history of BCC \[[@CR14], [@CR17], [@CR20], [@CR21], [@CR25], [@CR28], [@CR32]\]. Two males reported prior trauma to the chest (2/27, 7.4%) \[[@CR14], [@CR21]\]. One male had basal cell nevus syndrome (1/27, 3.7%) \[[@CR28]\], and one male was immunosuppressed on chemotherapy for gastric cancer (1/27, 3.7%) \[[@CR31]\].

To date, there have been eight patients with clinically pigmented BCCs of the NAC. Therefore, primary melanoma of the NAC, pigmented Paget disease, and pigmented epidermotropic metastases are important considerations in the clinical differential diagnosis of a pigmented lesion of the NAC. These can be differentiated by histologic examination and immunohistochemistry markers, such as CEA, cytokeratins, EMA, HMB-45, MART1, microphthalmia transcription factor (MiTF), and S-100 \[[@CR29], [@CR57]\].

Interestingly, two patients (including the patient described in Figs. [1](#Fig1){ref-type="fig"} and [2](#Fig2){ref-type="fig"}) with histologic findings of pigmented BCC had flesh-colored non-pigmented clinical lesions \[[@CR50]\]. The clinical presentation of one male with microscopic pigmented BCC was not described \[[@CR6]\].

Confirmation of BCC of the NAC requires a biopsy, although other approaches are available to evaluate a suspected diagnosis of BCC, including confocal laser scanning microscopy and dermoscopy.

Confocal laser scanning microscopy, also known as reflective confocal microscopy, is a noninvasive diagnostic method that enables real-time imaging of the skin layers and cellular structures in the horizontal plane \[[@CR58]\]. Classical findings of BCC on confocal laser scanning microscopy include five confocal imaging criteria: presence of elongated monomorphic basaloid nuclei, polarization of these nuclei along the same axis of orientation, heavy inflammatory infiltrate, increased vasculature, and pleomorphism of the overlying epidermis indicating actinic damage \[[@CR59]\].

Dermoscopy is another noninvasive method that allows for the in vivo evaluation of structures and colors of the epidermis, dermoepidermal junction, and papillary dermis not visible to the unaided eye. Dermoscopic diagnosis of BCC involves the absence of a pigmented network and presence of at least one of the following classical criteria: multiple blue-gray globules, large blue-gray ovoid nests, maple leaf-like areas, spoke-wheel areas, arborizing telangiectasia, and ulceration \[[@CR60]\]. Non-classical dermoscopic criteria are also helpful for the diagnosis of BCCs, especially early lesions, and include short fine superficial telangiectasia, concentric structures, multiple small erosions, multiple in-focus blue-gray dots, blue whitish veil, shiny pink-white areas, and milia-like cysts \[[@CR61]\].

Due to the infrequent presentation of BCC of the NAC, there has been a lack of characteristic findings in the literature to aid in the diagnosis of BCC of the NAC. However, a recent review by Kitamura et al. revealed a dermoscopic feature of pigmented BCC of the NAC that was termed a 'large black web.' On dermoscopic evaluation, it was noted that the black network structure was thicker than the typical pigment network of the areola, and the surrounding area consisted of arborizing vessels and spoke-wheel areas. When this patient was compared with nine others diagnosed with superficial BCC of the trunk, the authors found that the 'large black web' was unique to BCC of the NAC and appeared to avoid the hair follicles \[[@CR33]\].

Earlier investigations have reported an increased metastatic potential of BCC of the nipple and areola. These studies hypothesized that the increased lymphatics of the NAC may provide a direct route for tumor spread. There have been three cases of BCC of the NAC with lymph node involvement (Table [1](#Tab1){ref-type="table"}, cases 2, 5, and 12) \[[@CR2], [@CR5], [@CR8]\], which is a minimum metastatic rate of 5.5%. Since the outcome was not stated in ten patients and several patients had a short duration of follow-up after surgery, this rate could potentially be higher.

The histologic subtypes observed were most commonly nodular (42.9%) and superficial (30.9%); less often they showed pigment microscopically (11/42, 26.2%), mixed histology (16.7%), or fibroepithioloma of Pinkus variant (9.5%). Of the mixed subtypes, four cases were noted to have features associated with aggressive subtypes, such as infiltrative (3/7, 42.9%) and micronodular (1/7, 14.3%) BCCs.

Given the concern for higher metastatic potential or the presence of positive excision margins for tumors, nine patients underwent a simple mastectomy, although tissue-sparing surgery, such as simple excision, wide local excision, and Mohs micrographic surgery, was most commonly utilized. Recurrence of NAC BCC is low and was noted in one male who demonstrated lymph node involvement that occurred 4 years after simple excision \[[@CR2]\].

Conclusion {#Sec5}
==========

BCC of the NAC has been reported in 55 individuals. More males were affected than females; the left side was affected more than the right. Most commonly, these tumors presented as plaques with ulceration. The most frequent histologic subtype of BCC of NAC was nodular BCC. Although previous reports raise the concern of metastatic potential, most patients have been successfully treated with excision of the tumor.
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